Clinical Trial Design in Neuromodulation

Moderator(s)

• 

  Megan Frankowski, PhD

  Program Director
  National Institutes of Health
  North Bethesda, Maryland, United States

Co-Moderator(s)

• 

  Svjetlana Miocinovic, MD, PhD

  Associate Professor
  Neurology
  Emory University
  Atlanta, Georgia, United States

Speaker(s)

• 

  Helen Mayberg, MD

  Director, Center for Advanced Circuit Therapeutics Professor, Neurology, Neurosurgery, Psychiatry, Neuroscience, AI & Human Health Mount Sinai Professor of Neurotherapeutics
  Icahn School of Medicine at Mount Sinai
  New York City, New York, United States
• 

  DeLea Peichel, BS

  Senior Director, Global Clinical Operations
  Nevro Corp
  CARROLLTON, Texas, United States
• 

  Charity Patterson, PhD, MSPH

  Professor and Director
  University of Pittsburgh
  Pittsburgh, Pennsylvania, United States
• 

  Julie Goode

  Vice President Clinical Affairs
  Motif Neurotech
  Austin, Texas, United States

This session explores key aspects of clinical trial design in neuromodulation, including sham controls, multi-arm crossovers, and placebos. Drawing from personal experience, speakers and attendees will discuss benefits, challenges, and best practices to ensure rigorous, effective studies that advance the field and improve patient outcomes.